Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Evogene Ltd Ord (EVGN)

Evogene Ltd Ord (EVGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Evogene: Q3 Earnings Snapshot

Evogene: Q3 Earnings Snapshot

EVGN : 1.1100 (+0.91%)
Evogene Reports Third Quarter 2025 Financial Results

Conference call and webcast: today, November 20, 2025, 9:00 AM ET

EVGN : 1.1100 (+0.91%)
Casterra and Fantini Partner to Advance Agricultural Mechanization for Scalable Commercial Castor Farming

Collaboration focuses on integrating high-yield castor varieties with advanced mechanized solutions, including harvesting and threshing technologies

EVGN : 1.1100 (+0.91%)
Evogene Schedules Third Quarter 2025 Financial Results Release

Zoom conference call scheduled for November 20, 2025, 9:00 AM ET

EVGN : 1.1100 (+0.91%)
Evogene to Present at H.C. Wainwright 27th Annual Global Investment Conference in New York

REHOVOT, Israel , Aug. 28, 2025 /PRNewswire/ -- Evogene Ltd. (NASDAQ : EVGN) (TASE: EVGN), a leading computational biology and chemistry company, today announced that Ofer...

EVGN : 1.1100 (+0.91%)
Evogene: Q2 Earnings Snapshot

Evogene: Q2 Earnings Snapshot

EVGN : 1.1100 (+0.91%)
Evogene Reports Second Quarter 2025 Financial Results

Conference call and webcast: today, August 19, 2025 , 9:00 am ET

EVGN : 1.1100 (+0.91%)
Evogene and Professor Ehud Gazit of Tel Aviv University Announce a Collaboration to Develop New Therapeutics for Metabolic Diseases

A failure in metabolite breakdown leads to their ordered self-assembly into pathological aggregates, such as in Tyrosinemia   and Gout.

EVGN : 1.1100 (+0.91%)
Evogene Schedules Second Quarter 2025 Financial Results Release

Zoom conference call scheduled for August 19, 2025 , 9:00 AM ET

EVGN : 1.1100 (+0.91%)
Evogene: Q1 Earnings Snapshot

Evogene: Q1 Earnings Snapshot

EVGN : 1.1100 (+0.91%)

Barchart Exclusives

What Do We Know About the US Soybean Market?
The US soybean market had changed dramatically from the end of September through the end of October, all while the US government was in the dark. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar